Compound Summary
Compound Name: | Meloxicam sodium |
Compound CID: | 4051 |
Synonyms: | Meloxicam sodium NCGC00015671-01 Lopac-M-3935 MLS002153247 CHEMBL1256873 More... |
Iupac Name: | sodium;2-methyl-3-[(5-methyl-1,3-thiazol-2-yl)carbamoyl]-1,1-dioxo-1lambda6,2-benzothiazin-4-olate |
InChI: | InChI=1S/C14H13N3O4S2.Na/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2;/h3-7,18H,1-2H3,(H,15,16,19);/q;+1/p-1 |
InChIKey: | PTCPMRKGGUPNDO-UHFFFAOYSA-M |
Canonical Smiles: | CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)[O-].[Na+] |
Isomeric Smiles: | CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)[O-].[Na+] |
Molecular Weight: | 373.4 |
Molecular Formula: | C14H12N3NaO4S2 |
Molecular Weight: | 373.4 |
Molecular Formula: | C14H12N3NaO4S2 |
Hydrogen Bond Donor Count: | 1 |
Hydrogen Bond Acceptor Count: | 7 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 24 |
Complexity: | 634 |
Meloxicam sodium | Meloxicam sodium |
---|---|
Meloxicam sodium |
NCGC00015671-01 |
Lopac-M-3935 |
MLS002153247 |
CHEMBL1256873 |
DTXSID601017452 |
HMS2094I11 |
HMS2235M13 |
HMS3262I14 |
HMS3369C08 |
Tox21_500766 |
CCG-204851 |
CCG-213268 |
LP00766 |
SDCCGSBI-0050744.P002 |
NCGC00015671-02 |
NCGC00015671-03 |
NCGC00015671-04 |
NCGC00094105-01 |
NCGC00094105-02 |
NCGC00261451-01 |
SMR001230703 |
EU-0100766 |
M 3935 |
Sodium 2-methyl-3-((5-methylthiazol-2-yl)carbamoyl)-2H-benzoe1,2thiazin-4-olate 1,1-dioxide |
Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 33.000000000000000 | umol/L | 2.000000000000000 | NS | N2 | 24134630 | Inactive |
Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | 2.000000000000000 | 1 | 1 |